Nature medicine, 2010-09, Vol.16 (9), p.991-994
2010
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- Ist Teil von
- Nature medicine, 2010-09, Vol.16 (9), p.991-994
- Ort / Verlag
- New York: Nature Publishing Group US
- Erscheinungsjahr
- 2010
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects >60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1078-8956eISSN: 1546-170XDOI: 10.1038/nm.2202Titel-ID: cdi_proquest_miscellaneous_762279585
- Format
- –
- Schlagworte
- 631/61/51/391/1914, 692/699/255/2514, Animals, Antisense drugs, Biomedical and Life Sciences, Biomedicine, brief-communication, Cancer Research, Cynomolgus, Drug dosages, Drug therapy, Ebola virus, Ebolavirus - isolation & purification, Filoviridae Infections - genetics, Filoviridae Infections - immunology, Filoviridae Infections - mortality, Filoviridae Infections - prevention & control, Filovirus, Health aspects, Hemorrhagic Fever, Ebola - genetics, Hemorrhagic Fever, Ebola - immunology, Hemorrhagic Fever, Ebola - prevention & control, Humans, Infections, Infectious Diseases, Lakes, Macaca mulatta, Macaca mulatta - immunology, Marburg virus, Marburg virus disease, Marburg Virus Disease - genetics, Marburg Virus Disease - immunology, Marburg Virus Disease - prevention & control, Marburgvirus - isolation & purification, Metabolic Diseases, Molecular Medicine, Monkeys & apes, Neurosciences, Primates, Safety, Vaccines, Vaccines, Synthetic - therapeutic use, Viral Vaccines - therapeutic use, Virus diseases, Viruses